PHM de Mulder
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Ovarian cancer diagnosis and treatment, Renal cell carcinoma treatment, Bladder and Urothelial Cancer Treatments, Testicular diseases and treatments
Most-Cited Works
- → Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumours(2005)542 cited
- → A phase II trial of chimeric monoclonal antibody G250 for advanced renal cell carcinoma patients(2004)173 cited
- → Prognostic factors for survival in patients with advanced renal cell carcinoma treated with recombinant interleukin-2(1992)156 cited
- → Psychosocial interventions for patients with advanced cancer – a systematic review of the literature(2004)142 cited
- → A phase II study of Gemcitabine (LY 188011) in patients with advanced squamous cell carcinoma of the head and neck(1994)135 cited
- → Comparison of the anti-emetic efficacy of different doses of ondansetron, given as either a continuous infusion or a single intravenous dose, in acute cisplatin-induced emesis. A multicentre, double-blind, randomised, parallel group study(1992)102 cited
- → Four cycles of BEP versus an alternating regime of PVB and BEP in patients with poor-prognosis metastatic testicular non-seminoma; a randomised study of the EORTC Genitourinary Tract Cancer Cooperative Group(1995)99 cited
- → Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I–II feasibility study(2004)86 cited
- → EORTC (30885) randomised phase III study with recombinant interferon alpha and recombinant interferon alpha and gamma in patients with advanced renal cell carcinoma(1995)69 cited
- → Phase II study on gemcitabine in recurrent and/or metastatic adenoid cystic carcinoma of the head and neck (EORTC 24982)(2008)64 cited